R&D management in the pharma industry: the strategic role of CROs

  • PARENTE, ROBERTO
  • FEOLA, ROSANGELA
  • CUCINO, VALENTINA
  • et al.
N/ACitations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Purpose of the paper: This paper proposes a framework based on the concept of value-in-use generation for both stakeholders and companies. From a managerial perspective, value-in-use offers a useful tool to define strategies in the context of growing demand for corporate behaviours that demonstrate awareness and respect for the needs of all individuals. Methodology : Theoretical paper. Findings : The paper contributes to management studies by introducing a fresh insight on strategic analysis and through the concept of integrated value-in-use proposes an alternative model to interpret reality, which integrates the perspectives of management and marketing. Research limits : The main limits of this paper are its theoretical nature and lack of empirical research. Practical implications : This paper contributes to managerial practices by proposing a framework to support strategic analysis and positioning choices within markets and networks. Originality of the paper : This paper contributes to the debate on business strategy by providing the innovative concept of “integrated value-in-use” as a criterion for business choices, especially strategic ones.

Cite

CITATION STYLE

APA

PARENTE, ROBERTO, FEOLA, ROSANGELA, CUCINO, VALENTINA, & GIMIGLIANO, ANNA. (2018). R&D management in the pharma industry: the strategic role of CROs. Sinergie Italian Journal of Management, (101), 37–52. https://doi.org/10.7433/s101.2016.03

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free